OSSI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 1.729
EU - Europa 276
AS - Asia 230
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.240
Nazione #
US - Stati Uniti d'America 1.729
CN - Cina 168
FI - Finlandia 81
IT - Italia 59
SE - Svezia 39
DE - Germania 35
VN - Vietnam 34
SG - Singapore 23
RO - Romania 17
UA - Ucraina 14
GB - Regno Unito 11
IE - Irlanda 9
FR - Francia 8
EU - Europa 5
HK - Hong Kong 2
IN - India 2
RU - Federazione Russa 2
NO - Norvegia 1
PH - Filippine 1
Totale 2.240
Città #
Chandler 258
Fairfield 194
Woodbridge 171
Houston 131
Wilmington 97
Ann Arbor 80
Ashburn 75
Princeton 70
Seattle 61
Jacksonville 60
Roxbury 58
Medford 55
Cambridge 49
Nanjing 45
Beijing 44
Dong Ket 34
Des Moines 32
Boardman 29
San Diego 27
Falls Church 20
Helsinki 19
Horia 17
Singapore 14
Hebei 10
Shenyang 10
Dublin 9
Norwalk 9
Guangzhou 8
Mestre 8
Venice 8
Dearborn 7
Nanchang 7
New York 6
Tianjin 5
Borås 4
Changsha 4
Jiaxing 4
London 4
Milan 4
Redmond 3
Rome 3
Washington 3
Bari 2
Hong Kong 2
Kharkiv 2
Ogden 2
Padova 2
Redwood City 2
Zhengzhou 2
Atlanta 1
Bologna 1
Chapel Hill 1
Chicago 1
Chongqing 1
Davao City 1
Edinburgh 1
Fano 1
Florence 1
Gioia del Colle 1
Haikou 1
Hefei 1
Hounslow 1
Jinan 1
Kilburn 1
Kunming 1
Lanzhou 1
Livorno 1
Los Angeles 1
Mountain View 1
Orange 1
Oslo 1
Palermo 1
Reggio Nell'emilia 1
Rockville 1
Southwark 1
Tappahannock 1
Villingen-Schwenningen 1
Wuhan 1
Totale 1.799
Nome #
Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura. 105
Deep Venous Thrombosis After Surgery for Inflammatory Bowel Disease: Is Standard Dose Low Molecular Weight Heparin Prophylaxis Enough? 100
Cytokine network in chronic perianal Crohn's disease and indeterminate colitis after colectomy 90
MUSCLE BIOPSY STUDIES IN LIVER CIRRHOSIS 84
Von Willebrand factor abnormalities in IgA nephropathy. 74
Experimental peritoneal fibrosis: Favorable effects of glycosaminoglycans (GAGS) 62
Calcium and phosphorus metabolism in chronic uremia. 61
Left main trunk ostial stenosis and aortic incompetence in Takayasu's arteritis 57
Letter: Treatment of ascites. 53
IL TEST ALLA SECRETINA E PANCREOZIMINA NELLO STUDIO DELLE MALATTIE DEL PANCREAS ESOCRINO. CONFRONTO FRA INIEZIONE UNICA E INFUSIONE CONTINUA DEGLI ORMONI 52
Biochemical and morphological aspects of bone tissue in chronic renal failure. 51
FATTORE DI VON WILLEBRAND E PROGNOSI DELLA GLOMERULO-NEFRITE A DEPOSITI MESANGIALI DI IgA 50
ACID-BASE DISORDERS IN RENAL FAILURE 50
3) UN NUOVO METODO DI ANALISI DEL pH INTRACELLULARE NEL TESSUTO MUSCOLARE PRELEVATO MEDIANTE AGOBIOPSIA 48
[Effect of acute hypercalcemia on renal clearance of calcium and phosphorus in chronic uremia]. 47
THE DIAGNOSTIC VALUE OF IgA IMMUNOGLOBULINS IN PATIENTS WITH ASYMPTOMATIC URINARY ABNORMALITIES 47
IL METABOLISMO IDRO-ELETTROLITICO NELLE MALATTIE DEL RENE (FISIOPATOLOGIA CLINICA E TERAPIA) 44
[Aspects of protein metabolism in chronic uremia. Study completed with the help of nitrogen balance during a course of periodic hemodialysis]. 44
[Preliminary study of the use of lactulose (1,4-beta-galactoside-fructose) in the long-term treatment of portal systemic encephalopathy]. 44
Some observations on renal tubular acidosis secondary to interstitial or malformative kidney disease. Effects of treatment with NaHCO3. 42
INDAGINI SUL METABOLISMO IDROELETTROLITICO NELLA CIRROSI EPATICA (EFFETTI DELLA TERAPIA CON SPIRONOLATTONE) 42
[Behavior of intercellular pH in chronic uremia]. 41
The renal handling of calcium in normal subjects and in renal disease. 41
[On several cases of renal tubular acidosis secondary to interstitial or malformation nephropathies. Effects of treatment with NaHCO- 3 ]. 41
Effects of high doses of frusemide on plasma and muscle electrolytes in patients with chronic renal failure. 36
[Analysis of the body distribution of calcium in patients with kidney diseases with and without renal insufficiency]. 35
INDICAZIONI E LIMITI DELLA TERAPIA DIURETICA NELLA CIRROSI EPATICA 35
SIGNIFICATIVITA’ DI ALCUNI PARAMETRI DI FUNZIONALITA’ TUBULARE NELLA PIELONEFRITE SPERIMENTALE 34
EFFETTI DELLA TERAPIA DIURETICA CON DOSI ELEVATE DI FUROSEMIDE NELL'UREMIA CRONICA 31
RENO-PORTAL VEIN AND SIDE TO SIDE ANASTOMOSIS IN THE RAT 30
Interactions between metals in rat liver and kidney: localization of metallothionein 30
Aspects of calcium metabolism in obstructive nephropathy: a metabolic and bone biopsy investigation. 29
EFFETTI DELLA SOMMINISTRAZIONE ENDOVENOSA DI AMINOACIDI ESSENZIALI NELL'INSUFFICIENZA RENALE CRONICA 28
RENO-PORTAL VEIN AND SIDE TO SIDE ANASTOMOSIS IN THE RAT 27
DEFECTIVE MINERALIZATION IN CHRONIC GLOMERULONEPHRITS WITH NORMAL RENAL FUNCTION OR WITH EARLY RENAL INSUFFICIENCY 27
[Treatment of refractory ascites by re-infusionof ascitic fluid]. 26
[Metabolic disorders due to diuretic therapy]. 26
ASPETTI DEL METABOLISMO PROTIDICO NELL’UREMIA CRONICA 26
Aspects of phosphate metabolism in kidney disease. The pre-eminence of extrarenal factors. 25
IL TRATTAMENTO DELL'ASCITE REFRATTARIA MEDIANTE REINFUSIONE DI LIQUIDO ASCITICO 25
INFLUENZA DELL’IPERTENSIONE ARTERIOSA PRIMITIVA E SECONDARIA SUL TRASPORTO RENALE DEI FOSFATI 25
MORPHOLOGICAL ASPECTS OF BONE TISSUE IN CHRONIC RENAL FAILURE CONSERVATIVELY TREATED AND REGULAR DIALYSIS TREATMENT: A HISTOLOGICAL, ELECTRON MICROSCOPIC AND HISTOCHEMICAL STUDY 25
THE NITROGEN METABOLISM IN CHRONIC UREMIA (EFFECTS OF ESSENTIAL AMINO ACID ADMINISTRATION IN NONDIALYZED AND IN DIALYZED CHRONIC UREMIC PATIENTS) 24
[Residual diuresis in patients with chronic uremia on periodical hemodialysis]. 24
FISIOPATOLOGIA DELLE ALTERAZIONI DEL METABOLISMO FOSFOCALCICO NELL'UREMIA CRONICA 23
ASPETTI DEL METABOLISMO DELL'AZOTO NELL'UREMIA CRONICA (RILIEVI COMPIUTI IN PAZIENTI IN TRATTAMENTO CONSERVATIVO ED IN PAZIENTI IN EMODIALISI BI O TRISETTIMANALE) 23
VERTEBRAL FRACTURES AND DIALYSIS 23
[Aspects of phosphorus-calcium metabolism in obstructive nephropathy]. 22
[Aspects of water-electrolyte metabolism in polycystic kidney and in chronic glomerulonephritis. Effects of intravenous infusion of calcium]. 21
[Aspects of water-electrolyte metabolism studied with muscle needle-biopsy. Findings in cardiac insufficiency, hepatic cirrhosis, diabetes mellitus and chronic renal insufficiency]. 20
[Clinico-morphological correlations in uremic osteodystrophy of patients with conservative and hemodialytic treatment with special regard to the ultrastructure]. 19
Alterations in renal tubular sodium and water transport in polycystic kidney disease. 18
Renal tubular defects in recurring bilateral nephrolithiasis. 17
ASPETTI DEL METABOLISMO FOSFO-CALCICO NELLA NEFROPATIA OSTRUTTIVA 17
IL TEST ALLA SECRETINA E PANCREOZIMINA NELLO STUDIO DELLE MALATTIE CRONICHE DEL PANCREAS ESOCRINO 16
Glycosaminoglycans prevent the functional and morfphological peritoneal derangment in an experimental model of peritoneal fibrosis 15
Renal structure and function in non-insulin dependent diabetic patients with microalbuminura 15
MODERNI ORIENTAMENTI IN TEMA DI FISIOPATOLOGIA DEL METABOLISMO IDRO-ELETTROLITICO NELLA CIRROSI EPATICA 13
ANASTOMOSI VENA RENALE DS. PORTA TERMINO LATERALE, UN NUOVO MODELLO SPERIMENTALE NEL RATTO 13
ASPETTI DEL METABOLISMO FOSFO-CALCICO NELLA NEFROPATIA OSTRUTTIVA 12
MORPHOLOGICAL ASPECTS OF BONE TISSUE IN CHRONIC RENAL DISEASE. A HISTOLOGICAL AND ELECTRON MICROSCOPIC STUDY 12
CORRELAZIONI CLINICO-MORFOLOGICHE NELL’OSTEODISTROFIA UREMICA DI PAZIENTI IN TERAPIA CONSERVATIVA E IN TRATTAMENTO EMODIALITICO, CON PARTICOLARE RIFERIMENTO ALL’ULTRASTRUTTURA , 10
Totale 2.247
Categoria #
all - tutte 8.590
article - articoli 6.477
book - libri 183
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 71
Totale 15.321


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201961 0 0 0 0 0 0 0 0 0 0 32 29
2019/2020331 92 7 6 16 32 23 24 30 29 39 18 15
2020/2021169 14 7 3 13 3 8 2 37 17 8 16 41
2021/2022553 1 128 17 55 5 22 31 48 5 2 33 206
2022/2023489 106 60 1 66 98 64 1 21 42 2 22 6
2023/2024192 12 22 31 24 17 23 16 14 5 1 27 0
Totale 2.247